Richard Godfrey joined @BGenBio as CEO in 2008, he has extensive international drug development and commercial experience.
— Sachs Associates (@SachsAssociates) April 7, 2021
e-Meet Richard at #Sachs_IOIF
More info @ https://t.co/tMBHnCypoC pic.twitter.com/ycWvovGTsX